Aim: To investigate the association between apolipoprotein E (APOE) -219 T>G promoter polymorphism and primary open angle glaucoma (POAG).
Methods: Patients and healthy subjects were genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Genotype/allele frequencies were compared between 122 healthy subjects and in 75 POAG patients using Chi-square test.
Results: Although the frequency of APOE -219 GG genotype was higher in POAG group (13.3%) than in control group (6.6%), this finding was not statistically significant (P=0.09). In glaucoma patients carrying GG genotype, mean linear C/D ratio was higher and progression was more compared to glaucoma patients with GT genotype.
Conclusion: APOE -219 T>G polymorphism does not seem to be a risk factor for the presence of glaucoma, but might play a role in deterioration of the disease, which needs further evaluation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067653 | PMC |
| http://dx.doi.org/10.3980/j.issn.2222-3959.2014.03.07 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and assessment of algorithms for predicting brain amyloid positivity in a population without dementia.
Alzheimers Res Ther
October 2024
Univ. Bordeaux, Bordeaux Population Health, UMR1219, Inserm, Bordeaux, France.
Article Synopsis
- The study focuses on identifying brain amyloid positivity in non-demented individuals, which is vital for early Alzheimer's disease diagnosis and treatment to start before symptoms appear.
- Researchers developed predictive models using data from 853 participants, analyzing various factors like demographics, cognitive tests, and biomarkers related to Alzheimer's.
- The best-performing model, which included blood biomarkers and ApoE status, achieved high accuracy rates (AUCs of 0.82 and 0.90) in predicting amyloid positivity, surpassing traditional models that relied only on demographic and cognitive data.
Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage.
J Neurol
August 2024
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Objectives: There is limited understanding of the differences between cerebral amyloid angiopathy (CAA) with and without intracerebral hemorrhage (ICH). This article aimed to describe the characteristics of CAA and identify the risk factors of CAA-ICH in a multicenter cohort.
Methods: Patients consecutively enrolled in the national multicenter prospective Cerebral Small Vessel Disease Cohort Study who met the Boston diagnostic criteria for CAA or CAA-related inflammation were included in this study.
Molecular mechanisms implicated in protein changes in the Alzheimer's disease human hippocampus.
Mech Ageing Dev
June 2024
Department of Public Health, Hong Bang Health Center, Hai Phong, Vietnam.
This study aimed to elucidate the specific biochemical pathways linked to changes in proteins in the Alzheimer's disease (AD) human hippocampus. Our data demonstrate a constant rise in the expression of four proteins (VGF, GFAP, HSPB1, and APP) across all eleven studies. Notably, UBC was the most centrally involved and had increased expression in the hippocampus tissue of individuals with AD.
View Article and Find Full Text PDFMitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis.
Mech Ageing Dev
June 2024
Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research, Ghaziabad 201002, India. Electronic address:
Impaired mitochondrial fatty acid β-oxidation (FAO) plays a role in the onset of several age-associated diseases, including atherosclerosis. In the current work, we investigated the efficacies of mitochondria-targeted esculetin (Mito-Esc) and metformin in enhancing FAO in human aortic endothelial cells (HAECs), and its relevance in the delay of cellular senescence and age-associated atherosclerotic plaque formation in Apoe mice. Chronic culturing of HAECs with either Mito-Esc or metformin increased oxygen consumption rates (OCR), and caused delay in senescence features.
View Article and Find Full Text PDFApolipoprotein-E genotyping in formalin-fixed and paraffin-embedded post-mortem brain tissue.
Brain Pathol
September 2024
Faculty of Biology Medicine and Health, School of Biological Sciences, Division of Neuroscience, The University of Manchester, Manchester, UK.
Article Synopsis
- FFPE brain tissue in tissue banks is a valuable resource for research, especially with clinical data and psychological testing available.
- APOE genotyping is crucial for understanding this tissue, but older FFPE samples may not provide reliable results.
- The study found that DNA from FFPE brain tissue stored for more than three years may degrade, affecting APOE genotyping effectiveness.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!